We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Global X ETFS ICAV Global X Telemedicine & Digital Health UCITS ETF (EDOC)

Sell:$7.80 Buy:$7.84 0 Change: $0.0435 (0.56%)
Market closed |  Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$7.80
Buy:$7.84
Change: $0.0435 (0.56%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$7.80
Buy:$7.84
Change: $0.0435 (0.56%)
Market closed |  Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$7.77
Trade high:
$7.73
Year high:
$8.21
Market Listing:
London
Previous close:
$7.77
Trade low:
$7.73
Year low:
$6.76
Size:
$16.31M
Previous:
$0.14 (1.83%) Previous:
$0.14
Volume:
25
Dividend yield:
n/a
Currency:
USD
Data delayed by at least 15 minutes.

Chart Chart

GX TMEDDIGHLTH performance chart

ETP Basics

Issuer: Global X ETFs ICAV
Structure: ETF
Replication method: Stocks - Full Replication
Securities lending: No
Number of holdings: 40
Size: $16.3M
Launch date: 17 December 2020
Launch price: n/a
UCITS: Yes
Reporting status: Yes
Domicile: Ireland
Complex product: Non-complex
ISIN: IE00BLR6QB00

Annual & interim reports

Before you invest, please make sure you read the documents below

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents

There are no documents available for this stock.

OBJECTIVE

Index: The Index aims to provide exposure to exchange-listed companies that are positioned to benefit from advances and application of advances in the field of telemedicine and digital health (collectively “Telemedicine & Digital Health Companies”). A company must derive at least 50% of its revenue, operating income, or assets from telemedicine and/or digital health to be considered for inclusion in the Index. Telemedicine and Digital Health Companies include those involved in the following business activities (i) telemedicine, (ii) healthcare analytics, (iii) connected healthcare devices and/or (iv) administrative digitisation.
Aim: The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to invest in...
Read full aim for Global X ETFS ICAV
Leverage: 100%
Currency hedging: n/a

COSTS

Ongoing Charge (OCF/TER): 0.68%
Management fee: 0.68%
Indicative spread: 0.59%

In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.

Performance

1 week 1W 3.47% 1 year 1Y 9.76%
1 month 1M 2.86% 2 years 2Y 15.39%
3 months 3M 6.08% 3 years 3Y 42.89%
6 months 6M 4.64% 5 years 5Y n/a

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Security Weight
MEDLEY INC 42.34%
ALIBABA HEALTH INFORMATION TECH LTD 13.85%
JD HEALTH INTL INC 12.90%
PING AN HEALTHCARE & TECHNO CO LTD 4.86%
RESMED INC 1.69%
MASIMO CORP 1.63%
DOXIMITY INC 1.55%
DEXCOM 1.44%
AGILENT TECHNOLOGIES INC 1.23%
LABORATORY CORP OF AMERICA HLDGS 1.19%
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data provided by Broadridge. Some of the data on this page and other related pages is provided to you for your information and is received from the Fund Management Company administering this fund. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties. Securities lending data correct as at date not available. Charge data correct as at date not available. Holdings correct as at 21 March 2023.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.